The Food and Drug Administration (FDA) requires Brightfield Group online data subscription and analytic services to help address knowledge gaps on cannabis, cannabidiol (CBD), and emerging products an... The Food and Drug Administration (FDA) requires Brightfield Group online data subscription and analytic services to help address knowledge gaps on cannabis, cannabidiol (CBD), and emerging products and help inform work on policy and regulation, education and outreach, and compliance activities.